Authors:
Prasher, JM
Elenitoba-Johnson, KSJ
Kelley, LL
Citation: Jm. Prasher et al., Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia, ONCOGENE, 20(23), 2001, pp. 2946-2955
Authors:
Hsieh, FF
Bamett, LA
Green, WF
Freedman, K
Matushansky, I
Skoultchi, AI
Kelley, LL
Citation: Ff. Hsieh et al., Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase, BLOOD, 96(8), 2000, pp. 2646-2654
Authors:
Hsieh, FF
Barnett, LA
Green, WF
Freedman, K
Matushansky, I
Skoultchi, AI
Kelley, LL
Citation: Ff. Hsieh et al., Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase, BLOOD, 96(8), 2000, pp. 2746-2754
Authors:
Bills, AC
Green, WF
Tsodikov, A
Carey, MJ
Perkins, SL
Petersen, FB
Beatty, PG
Kelley, LL
Citation: Ac. Bills et al., Cytokeratin-positive cells in PBSC collections from normal donors and patients with non-epithelial cell-derived tumors, CYTOTHERAPY, 1(5), 1999, pp. 389-399